share_log

SomaLogic (NASDAQ:SLGC) Shares Gap Down to $3.00

SomaLogic (NASDAQ:SLGC) Shares Gap Down to $3.00

纳斯达克(Sequoia Capital：SLGC)股价下跌至3美元
Defense World ·  2022/09/28 04:42

SomaLogic, Inc. (NASDAQ:SLGC – Get Rating) gapped down before the market opened on Monday . The stock had previously closed at $3.00, but opened at $2.89. SomaLogic shares last traded at $2.96, with a volume of 15,629 shares.

周一开盘前，SomaLogic公司(纳斯达克代码：SLGC-GET Rating)股价下跌。该股此前收于3.00美元，但开盘报2.89美元。SomaLogic的股票最新报2.96美元，成交量为15,629股。

Analyst Ratings Changes

分析师评级发生变化

A number of brokerages have recently commented on SLGC. Cowen lowered their price target on shares of SomaLogic from $11.00 to $9.00 and set an "outperform" rating for the company in a report on Tuesday, August 16th. Cowen lowered their price target on shares of SomaLogic from $11.00 to $9.00 in a report on Tuesday, August 16th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, SomaLogic has a consensus rating of "Buy" and an average price target of $13.33.

多家券商近期纷纷对SLGC发表评论。考恩在8月16日周二的一份报告中将SomaLogic的股票目标价从11.00美元下调至9.00美元，并为该公司设定了“跑赢大盘”的评级。考恩在8月16日星期二的一份报告中将SomaLogic的目标股价从11.00美元下调至9.00美元。根据MarketBeat.com的数据，五位研究分析师将该股的评级定为买入，SomaLogic的普遍评级为买入，平均目标价为13.33美元。

Get
到达
SomaLogic
SomaLogic
alerts:
警报：

SomaLogic Stock Up 2.4 %

SomaLogic股价上涨2.4%

The company has a market cap of $544.86 million, a PE ratio of -3.58 and a beta of 1.53. The business's 50 day moving average price is $4.14 and its 200-day moving average price is $5.43.

该公司市值为5.4486亿美元，市盈率为-3.58，贝塔系数为1.53。该业务的50日移动均线价格为4.14美元，其200日移动均线价格为5.43美元。

Institutional Trading of SomaLogic

SomaLogic的机构交易

A number of hedge funds have recently made changes to their positions in SLGC. Vanguard Group Inc. raised its stake in shares of SomaLogic by 158.1% during the first quarter. Vanguard Group Inc. now owns 6,473,890 shares of the company's stock valued at $51,921,000 after purchasing an additional 3,965,138 shares during the period. Point72 Asset Management L.P. increased its stake in shares of SomaLogic by 190.2% in the fourth quarter. Point72 Asset Management L.P. now owns 3,720,666 shares of the company's stock worth $43,309,000 after buying an additional 2,438,734 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of SomaLogic by 2,913.7% in the first quarter. Goldman Sachs Group Inc. now owns 2,120,772 shares of the company's stock worth $17,009,000 after buying an additional 2,050,401 shares during the last quarter. State Street Corp increased its stake in shares of SomaLogic by 403.9% in the second quarter. State Street Corp now owns 2,510,507 shares of the company's stock worth $11,347,000 after buying an additional 2,012,256 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. bought a new stake in shares of SomaLogic in the second quarter worth $8,922,000. Hedge funds and other institutional investors own 59.29% of the company's stock.
一些对冲基金最近改变了他们在SLGC的头寸。先锋集团第一季度增持SomaLogic股份158.1%。先锋集团目前持有该公司6,473,890股股票，价值51,921,000美元，在此期间又购买了3,965,138股。Point72Asset Management L.P.在第四季度增持了SomaLogic的股份190.2%。Point72 Asset Management L.P.在上个季度额外购买了2,438,734股后，现在拥有3,720,666股该公司股票，价值43,309,000美元。高盛股份有限公司在第一季度增持了SomaLogic股份2,913.7%。高盛股份有限公司在上个季度增持了2,050,401股后，目前持有该公司2,120,772股股票，价值17,009,000美元。道富集团在第二季度增持了SomaLogic的股份403.9%。道富银行目前持有2,510,507股该公司股票，价值11,347,000美元，此前该公司在上一季度又购买了2,012,256股。最后，三井住友信托控股有限公司(Sumitomo Mitsui Trust Holdings Inc.)在第二季度购买了价值892.2万美元的SomaLogic新股。对冲基金和其他机构投资者持有该公司59.29%的股票。

SomaLogic Company Profile

SomaLogic公司简介

(Get Rating)

(获取评级)

SomaLogic, Inc operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.

SomaLogic公司在美国是一家蛋白质生物标记物发现和临床诊断公司。它开发慢速修饰适体(SOMAmers)，这是一种针对其同源蛋白质的改良核酸蛋白质结合试剂；并提供专有的SomaScan服务，提供复杂生物样本中的多重蛋白质检测和蛋白质水平的量化。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on SomaLogic (SLGC)
  • Defensive Stocks For A Volatile Market
  • Will UPS Be Next to Deliver a Warning?
  • SunPower Is Ready To Power Up Triple-Digit Earnings Gains
  • Is This the Darkest Before the Dawn for Gap Stock?
  • Build A Better Tech Portfolio With Jabil Inc.
  • 免费获取StockNews.com关于SomaLogic的研究报告(SLGC)
  • 防御性股票应对动荡的市场
  • UPS会成为下一个发出警告的公司吗？
  • SunPower准备推动三位数的收益增长
  • 这是Gap Stock黎明前最黑暗的一次吗？
  • 与捷普公司一起打造更好的技术产品组合。

Receive News & Ratings for SomaLogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomaLogic and related companies with MarketBeat.com's FREE daily email newsletter.

接受SomaLogic日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对SomaLogic和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发